MedPath
NMPA Approval

Sorafenib Tosylate Tablets

国药准字H20203397

August 5, 2020

Drug Information

甲苯磺酸索拉非尼片

利格思泰

片剂

0.2g(以索拉非尼计)

化学药品

August 5, 2020

Company Information

Applicant Company

江西省赣州经济技术开发区凤凰路116号

Manufacturing Company

江西省赣州经济技术开发区凤凰路116号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲苯磺酸索拉非尼片 - NMPA 批准文号 | MedPath